Cargando…
In vivo porcine characterization of atrial lesion safety and efficacy utilizing a circular pulsed‐field ablation catheter including assessment of collateral damage to adjacent tissue in supratherapeutic ablation applications
INTRODUCTION: Pulsed‐field ablation (PFA), an ablative method that causes cell death by irreversible electroporation, has potential safety advantages over radiofrequency ablation and cryoablation. Pulmonary vein (PV) isolation was performed in a porcine model to characterize safety and performance o...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545022/ https://www.ncbi.nlm.nih.gov/pubmed/35510408 http://dx.doi.org/10.1111/jce.15522 |
_version_ | 1784804727690625024 |
---|---|
author | Hsu, Jonathan C. Gibson, Douglas Banker, Rajesh Doshi, Shephal K. Gidney, Brett Gomez, Tara Berman, Dror Datta, Keshava Govari, Assaf Natale, Andrea |
author_facet | Hsu, Jonathan C. Gibson, Douglas Banker, Rajesh Doshi, Shephal K. Gidney, Brett Gomez, Tara Berman, Dror Datta, Keshava Govari, Assaf Natale, Andrea |
author_sort | Hsu, Jonathan C. |
collection | PubMed |
description | INTRODUCTION: Pulsed‐field ablation (PFA), an ablative method that causes cell death by irreversible electroporation, has potential safety advantages over radiofrequency ablation and cryoablation. Pulmonary vein (PV) isolation was performed in a porcine model to characterize safety and performance of a novel, fully‐integrated biphasic PFA system comprising a multi‐channel generator, variable loop circular catheter, and integrated PFA mapping software module. METHODS: Eight healthy porcine subjects were included. To evaluate safety, multiple ablations were performed, including sites not generally targeted for therapeutic ablation, such as the right inferior PV lumen, right superior PV ostium, and adjacent to the esophagus and phrenic nerve. To evaluate the efficacy, animals were recovered, followed for 30(±3) days, then re‐mapped. Gross pathological and histopathological examinations assessed procedural injuries, chronic thrombosis, tissue ablation, penetration depth, healing, and inflammatory response. RESULTS: All eight animals survived follow‐up. PV narrowing was not observed acutely nor at follow‐up, even when ablation was performed deep to the PV ostium. No injury was seen grossly or histologically in adjacent structures. All PVs were durably isolated, confirmed by bidirectional block at re‐map procedure. Histological examination showed complete, transmural necrosis around the circumference of the ablated section of right PVs. CONCLUSION: This preclinical evaluation of a fully‐integrated PFA system demonstrated effective and durable ablation of cardiac tissue and PV isolation without collateral damage to adjacent structures, even when ablation was performed in more extreme settings than those used therapeutically. Histological staining confirmed complete transmural cell necrosis around the circumference of the PV ostium at 30 days. |
format | Online Article Text |
id | pubmed-9545022 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95450222022-10-14 In vivo porcine characterization of atrial lesion safety and efficacy utilizing a circular pulsed‐field ablation catheter including assessment of collateral damage to adjacent tissue in supratherapeutic ablation applications Hsu, Jonathan C. Gibson, Douglas Banker, Rajesh Doshi, Shephal K. Gidney, Brett Gomez, Tara Berman, Dror Datta, Keshava Govari, Assaf Natale, Andrea J Cardiovasc Electrophysiol Original Articles INTRODUCTION: Pulsed‐field ablation (PFA), an ablative method that causes cell death by irreversible electroporation, has potential safety advantages over radiofrequency ablation and cryoablation. Pulmonary vein (PV) isolation was performed in a porcine model to characterize safety and performance of a novel, fully‐integrated biphasic PFA system comprising a multi‐channel generator, variable loop circular catheter, and integrated PFA mapping software module. METHODS: Eight healthy porcine subjects were included. To evaluate safety, multiple ablations were performed, including sites not generally targeted for therapeutic ablation, such as the right inferior PV lumen, right superior PV ostium, and adjacent to the esophagus and phrenic nerve. To evaluate the efficacy, animals were recovered, followed for 30(±3) days, then re‐mapped. Gross pathological and histopathological examinations assessed procedural injuries, chronic thrombosis, tissue ablation, penetration depth, healing, and inflammatory response. RESULTS: All eight animals survived follow‐up. PV narrowing was not observed acutely nor at follow‐up, even when ablation was performed deep to the PV ostium. No injury was seen grossly or histologically in adjacent structures. All PVs were durably isolated, confirmed by bidirectional block at re‐map procedure. Histological examination showed complete, transmural necrosis around the circumference of the ablated section of right PVs. CONCLUSION: This preclinical evaluation of a fully‐integrated PFA system demonstrated effective and durable ablation of cardiac tissue and PV isolation without collateral damage to adjacent structures, even when ablation was performed in more extreme settings than those used therapeutically. Histological staining confirmed complete transmural cell necrosis around the circumference of the PV ostium at 30 days. John Wiley and Sons Inc. 2022-05-16 2022-07 /pmc/articles/PMC9545022/ /pubmed/35510408 http://dx.doi.org/10.1111/jce.15522 Text en © 2022 The Authors. Journal of Cardiovascular Electrophysiology published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Hsu, Jonathan C. Gibson, Douglas Banker, Rajesh Doshi, Shephal K. Gidney, Brett Gomez, Tara Berman, Dror Datta, Keshava Govari, Assaf Natale, Andrea In vivo porcine characterization of atrial lesion safety and efficacy utilizing a circular pulsed‐field ablation catheter including assessment of collateral damage to adjacent tissue in supratherapeutic ablation applications |
title | In vivo porcine characterization of atrial lesion safety and efficacy utilizing a circular pulsed‐field ablation catheter including assessment of collateral damage to adjacent tissue in supratherapeutic ablation applications |
title_full | In vivo porcine characterization of atrial lesion safety and efficacy utilizing a circular pulsed‐field ablation catheter including assessment of collateral damage to adjacent tissue in supratherapeutic ablation applications |
title_fullStr | In vivo porcine characterization of atrial lesion safety and efficacy utilizing a circular pulsed‐field ablation catheter including assessment of collateral damage to adjacent tissue in supratherapeutic ablation applications |
title_full_unstemmed | In vivo porcine characterization of atrial lesion safety and efficacy utilizing a circular pulsed‐field ablation catheter including assessment of collateral damage to adjacent tissue in supratherapeutic ablation applications |
title_short | In vivo porcine characterization of atrial lesion safety and efficacy utilizing a circular pulsed‐field ablation catheter including assessment of collateral damage to adjacent tissue in supratherapeutic ablation applications |
title_sort | in vivo porcine characterization of atrial lesion safety and efficacy utilizing a circular pulsed‐field ablation catheter including assessment of collateral damage to adjacent tissue in supratherapeutic ablation applications |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545022/ https://www.ncbi.nlm.nih.gov/pubmed/35510408 http://dx.doi.org/10.1111/jce.15522 |
work_keys_str_mv | AT hsujonathanc invivoporcinecharacterizationofatriallesionsafetyandefficacyutilizingacircularpulsedfieldablationcatheterincludingassessmentofcollateraldamagetoadjacenttissueinsupratherapeuticablationapplications AT gibsondouglas invivoporcinecharacterizationofatriallesionsafetyandefficacyutilizingacircularpulsedfieldablationcatheterincludingassessmentofcollateraldamagetoadjacenttissueinsupratherapeuticablationapplications AT bankerrajesh invivoporcinecharacterizationofatriallesionsafetyandefficacyutilizingacircularpulsedfieldablationcatheterincludingassessmentofcollateraldamagetoadjacenttissueinsupratherapeuticablationapplications AT doshishephalk invivoporcinecharacterizationofatriallesionsafetyandefficacyutilizingacircularpulsedfieldablationcatheterincludingassessmentofcollateraldamagetoadjacenttissueinsupratherapeuticablationapplications AT gidneybrett invivoporcinecharacterizationofatriallesionsafetyandefficacyutilizingacircularpulsedfieldablationcatheterincludingassessmentofcollateraldamagetoadjacenttissueinsupratherapeuticablationapplications AT gomeztara invivoporcinecharacterizationofatriallesionsafetyandefficacyutilizingacircularpulsedfieldablationcatheterincludingassessmentofcollateraldamagetoadjacenttissueinsupratherapeuticablationapplications AT bermandror invivoporcinecharacterizationofatriallesionsafetyandefficacyutilizingacircularpulsedfieldablationcatheterincludingassessmentofcollateraldamagetoadjacenttissueinsupratherapeuticablationapplications AT dattakeshava invivoporcinecharacterizationofatriallesionsafetyandefficacyutilizingacircularpulsedfieldablationcatheterincludingassessmentofcollateraldamagetoadjacenttissueinsupratherapeuticablationapplications AT govariassaf invivoporcinecharacterizationofatriallesionsafetyandefficacyutilizingacircularpulsedfieldablationcatheterincludingassessmentofcollateraldamagetoadjacenttissueinsupratherapeuticablationapplications AT nataleandrea invivoporcinecharacterizationofatriallesionsafetyandefficacyutilizingacircularpulsedfieldablationcatheterincludingassessmentofcollateraldamagetoadjacenttissueinsupratherapeuticablationapplications |